Polaris Growth Management, LLC
Polaris Partners X, L.P.
Late investment period
Late investment period: first sale Feb 2022, per Form D (fund age approximates vintage)
- Vintage
- 2022
- Fund size
- $354.59M to $375.67M (Form D and SEC adviser filing)
- Stages
- Not stated
- Sectors
- Biotech, Healthtech
- Regions
- Not stated
01 · Thesis
Polaris backs transformational healthcare and biotech companies, from early-stage academic research and healthcare innovation to founder-owned growth companies, partnering with entrepreneurs as they build them.Inferred from the firm's website
02 · Initial check
$3.55M to $6.26M (estimated from fund size)
Estimated from Form D and SEC adviser filing
03 · Who to approach
Named on this fund's Form D
- Darren Carroll
- Amy Schulman, Managing Member of the General Partner
- Brian Chee, Managing Member of the General Partner
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-widePolaris is an investment firm with nearly 30 years of experience backing transformational healthcare and biotech companies.
We are an investment firm with nearly 30 years of experience backing transformational healthcare and biotech companies.
https://polarispartners.com/about/
06 · Sources
Last verified: Oct 28, 2026